Regulated Information
Financial Reports
06
May
2022
Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights
05
Aug
2022
Celyad Oncology Reports First Half 2022 Financial Results and Recent Business Highlights
SEC Filings
Filter
| Filing Date | Form | Description | Filing Group | Downloads |
|---|---|---|---|---|
| November 24, 2023 | 6-K | Report of Foreign Issuer: Celyad Oncology Reports Third Quarter 2023 Financial Results And Recent Business Highlights | Press release | |
| November 21, 2023 | 6-K | Report of Foreign Issuer: Publication Of A Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 Of The Law Of 2 May 2007) | Press release | |
| November 21, 2023 | 6-K | Report of Foreign Issuer: Celyad Oncology SA (the “Company”) published the convening letter to the extraordinary general meeting of shareholders of 22 December 2023 | Assemblees | |
| November 15, 2023 | 6-K | Report of Foreign Issuer: Information On The Total Number Of Voting Rights And Shares (Article 15 Of The Law Of 2 May 2007) | Press release | |
| October 27, 2023 | 6-K | Report of Foreign Issuer: Celyad Oncology SA (the “Company”) published the convening letter to the extraordinary general meeting of shareholders of 14 November 2023 | Assemblees | |
| September 26, 2023 | 6-K | Report of Foreign Issuer: Celyad Oncology Announces The Termination Of Its American Depository Receipt Program | Press release |
Regulated Information
Filter
Tolefi Transparency Notification dated 24 July 2026
Fortress Transparency Notification dated 20 November 2025
Fortress Transparency Notification dated 11 August 2025
